Angeles Wealth Management LLC Increases Stock Position in HCA Healthcare, Inc. $HCA

Angeles Wealth Management LLC grew its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 15.5% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 990 shares of the company’s stock after purchasing an additional 133 shares during the quarter. Angeles Wealth Management LLC’s holdings in HCA Healthcare were worth $379,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in HCA. Nuveen LLC purchased a new position in shares of HCA Healthcare in the first quarter valued at approximately $569,217,000. Pacer Advisors Inc. boosted its stake in shares of HCA Healthcare by 6,237.9% in the first quarter. Pacer Advisors Inc. now owns 1,350,933 shares of the company’s stock valued at $466,815,000 after purchasing an additional 1,329,618 shares during the period. Price T Rowe Associates Inc. MD boosted its stake in shares of HCA Healthcare by 83.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 2,399,372 shares of the company’s stock valued at $829,104,000 after purchasing an additional 1,091,416 shares during the period. Goldman Sachs Group Inc. raised its holdings in HCA Healthcare by 49.1% in the first quarter. Goldman Sachs Group Inc. now owns 1,781,459 shares of the company’s stock valued at $615,583,000 after acquiring an additional 587,036 shares in the last quarter. Finally, Abdiel Capital Advisors LP acquired a new stake in HCA Healthcare in the first quarter valued at approximately $164,835,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insiders Place Their Bets

In related news, EVP Michael S. Cuffe sold 3,836 shares of HCA Healthcare stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the transaction, the executive vice president directly owned 31,503 shares in the company, valued at $13,194,716.52. This trade represents a 10.85% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 1.30% of the stock is currently owned by company insiders.

HCA Healthcare Trading Up 1.4%

Shares of HCA opened at $425.50 on Friday. The firm has a market cap of $99.56 billion, a PE ratio of 17.89, a price-to-earnings-growth ratio of 1.33 and a beta of 1.40. The company’s 50 day simple moving average is $410.05 and its 200-day simple moving average is $378.21. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $439.01.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.20 by $0.64. The business had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same period last year, the firm posted $5.50 earnings per share. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th were given a dividend of $0.72 per share. The ex-dividend date was Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare’s dividend payout ratio (DPR) is 12.11%.

Analysts Set New Price Targets

Several analysts recently weighed in on the stock. JPMorgan Chase & Co. raised their target price on shares of HCA Healthcare from $360.00 to $370.00 and gave the company a “neutral” rating in a report on Monday, August 4th. Wolfe Research cut shares of HCA Healthcare from an “outperform” rating to a “peer perform” rating in a report on Monday, July 28th. Morgan Stanley cut their price objective on shares of HCA Healthcare from $410.00 to $400.00 and set an “equal weight” rating on the stock in a report on Monday, July 28th. Royal Bank Of Canada cut their price objective on shares of HCA Healthcare from $404.00 to $401.00 and set an “outperform” rating on the stock in a report on Monday, July 28th. Finally, Truist Financial set a $460.00 price objective on shares of HCA Healthcare in a report on Tuesday. One investment analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $434.00.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.